- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Leading global pharmaceutical products and respective revenues 2024
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Leading global pharmaceutical products and respective revenues 2024
Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
by Matej Mikulic,
last edited
Jun 19, 2019
This statistic shows a projection of the top 10 global pharmaceutical products and their respective revenues worldwide in 2024. AbbVie's and Eisai's Humira is expected to generate some 12.4 billion U.S. dollars in revenue by 2024.
Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
| Product (Company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Product (Company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jun 19, 2019
This statistic shows a projection of the top 10 global pharmaceutical products and their respective revenues worldwide in 2024. AbbVie's and Eisai's Humira is expected to generate some 12.4 billion U.S. dollars in revenue by 2024.
- Show sources information
- Show publisher information
- Release date
- June 2019
- Region
- Worldwide
- Survey time period
- as of May 2019
- Supplementary notes
- Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.
Source
- Show sources information
- Show publisher information
- Release date
- June 2019
More information
- Region
- Worldwide
- Survey time period
- as of May 2019
- Supplementary notes
- Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.
Other statistics on the topic
Global Pharmaceutical Industry
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Allergan
- 45 page/s
- English
- pptx
- Detailed references
Everything On "Allergan" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Leading global anti-viral products by market share 2017 and 2024
- Leading European vaccine products by market share 2015-2022
- Members of EFPIA's pharmaceutical exports and imports 1990-2018
- Retrospective rebates, discounts, and fees for brand medicines in US 2013-2015
- Mean cost of U.S. opioid marketing as of 2015, by census region
- Top drugs based on projected 2019 year-on-year sales increase
- Expenditure worldwide on diabetes by market 2013-2018
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Top U.S. proton pump inhibitors' revenue market share 2013
- Top U.S. proton pump inhibitors based on revenue 2013
- List price and rebate price change of select top drugs US 2009-2015
- Revenues of top diversified products of Bausch Health 2018
- Top U.S. proton pump inhibitors market share based on prescriptions 2013
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Projection of top 10 global pharmaceutical products by revenue 2019
- Spain: bile and other animal glands for pharmaceutical preparation 2012-2017
- Hungary: pharmaceutical goods export value 2012-2019
- Manufacture of optical and photographic equipment revenue in Norway 2010-2022
- France: medicament mixtures not in dosage import value 2012-2017
- Forecast: revenue pharmaceutical preparation manufacture Norway 2011-2020
Studies
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Meds Entry Watch 2017
- Meds Entry Watch 2016
- Prescribed Drug Spending in Canada, 2018
- Pharmaceutical trends in Europe
- Zoetis Annual Report 2018
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Patented Medicine Prices Review Board - Annual Report 2017
- Drug Use Among Seniors in Canada, 2016
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribed Drug Spending in Canada, 2017
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- PAGB Annual Review 2017-2018
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
Statistics on "Global pharmaceutical industry"
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Top 5 global anti-viral products by market share in 2017 and 2024
- Top 3 European vaccine products in 2015 and 2022 by market share
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2018 (in million euros)
- Retrospective rebates, discounts, and fees for brand medicines in the U.S. from 2013 to 2015 (in billion U.S. dollars)
- Mean cost of U.S. opioid pharmaceutical marketing per 1,000 population in 2013-2015, by census region (in U.S. dollars)
- Top drugs based on projected 2019 year-on-year sales increase (in billion U.S. dollars)
- Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
- Top HMG-CoA reductase inhibitors based on U.S. revenue market share in 2013
- Top proton pump inhibitors based on U.S. revenue market share in 2013
- Top proton pump inhibitors based on U.S. revenue in 2013 (in million U.S. dollars)
- List price and rebate price change of select top drugs in the U.S. between 2009 and 2015
- Revenues of Bausch Health Companies' top diversified products in 2018 (in million U.S. dollars)
- Top proton pump inhibitors based on U.S. prescriptions market share in 2013
- Top 10 proton pump inhibitors based on U.S. prescriptions in 2013 (in millions)
- Projected top 10 pharmaceutical products worldwide by revenue in 2019 (in billion U.S. dollars)
- Value of bile and other animal glands for pharmaceutical preparation exported from Spain from 2012 to 2017 (in 1,000 euros)
- Value of pharmaceutical goods exported from Hungary from 2001 to 2019 (in 1,000 GBP)
- Manufacture of optical and photographic equipment revenue in Norway from 2010 to 2022 (in million U.S. dollars)
- Value of medicament mixtures not in dosage imported to France from 2012 to 2017 (in 1,000 euros)
- Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Norway from 2011 to 2020 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.